Work

Abstract CT193: Trial in progress: A first-in-human phase 1a/b study of BGB-58067, an MTA-cooperative PRMT5 inhibitor, in patients with advanced solid tumors and MTAP deficiency

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct193

Authors: Brian A. Van Tine, Timothy Humphries, Sophie Postel-Vinay, Hui Gan, Ugonma Chuwueke, Tai Qin, Hayden Huang, Chunyu Wang, Yan Dong, Caicun Zhou

Institutions: Washington University in St. Louis, Linear Clinical Research, Institut Gustave Roussy, Austin Hospital, Dana-Farber Cancer Institute, BeiGene (China), Shanghai East Hospital

Language: English

Topic: Cancer-related gene regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822074

Cites:

Cited by: 2

Related to: 10